Your browser doesn't support javascript.
loading
A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
Karayama, Masato; Aoshima, Yoichiro; Suzuki, Takahito; Mori, Kazutaka; Yoshizawa, Nobuko; Ichikawa, Shintaro; Kato, Shinpei; Yokomura, Koshi; Kono, Masato; Hashimoto, Dai; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Goshima, Satoshi; Inui, Naoki; Suda, Takafumi.
Afiliação
  • Karayama M; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan karayama@hama-med.ac.jp.
  • Aoshima Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Suzuki T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Mori K; Department of Respiratory Medicine, Shizuoka City Shimizu Hospital, Shizuoka, Japan.
  • Yoshizawa N; Department of Radiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Ichikawa S; Department of Radiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Kato S; Department of Respiratory Medicine, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
  • Yokomura K; Department of Respiratory Medicine, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
  • Kono M; Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
  • Hashimoto D; Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
  • Inoue Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Yasui H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Hozumi H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Suzuki Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Furuhashi K; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Fujisawa T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Enomoto N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Goshima S; Department of Radiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Inui N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Suda T; Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Eur Respir J ; 61(5)2023 05.
Article em En | MEDLINE | ID: mdl-36822633
ABSTRACT

BACKGROUND:

Acute exacerbation of idiopathic interstitial pneumonias (AE-IIPs) induces permanent pulmonary dysfunction and is potentially lethal. The unpredictable occurrence of AE-IIPs remains an important clinical issue in the management of IIPs.

METHODS:

In this multicentre, retrospective, observational study, a predictive score for AE-IIPs was designed using clinical factors based on multivariate Fine-Gray analysis in patients with IIPs.

RESULTS:

Based on multivariate Fine-Gray analysis in an exploratory cohort of 487 patients with IIPs, the predictive score for AE-IIPs was determined as follows 1 point each was added for honeycombing on high-resolution computed tomography (H), age >75 years (A) and lactate dehydrogenase level >222 U·L-1 (L); the total score ranged from 0 to 3 (HAL score). The HAL score discriminated the risk of AE-IIPs with a C-index of 0.62 (95% CI 0.56-0.67); this discrimination was verified in a validation cohort of 402 patients with IIPs with a C-index of 0.67 (95% CI 0.60-0.73). In a combined cohort, the estimated cumulative risks for AE-IIPs at 1, 2, 3, 5 and 10 years were 1.9%, 3.5%, 5.1%, 7.7% and 12.9%, respectively, in the total score 0 group; 4.7%, 8.3%, 12.0%, 17.7% and 28.4%, respectively, in the total score 1 group; and 8.0%, 14.2%, 19.7%, 28.7% and 43.0%, respectively, in the total score ≥2 group. Subgroup analysis revealed that the HAL score was applicable to patients with and without idiopathic pulmonary fibrosis.

CONCLUSIONS:

The HAL score discriminated the risk of AE-IIPs and could aid in the management of IIPs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonias Intersticiais Idiopáticas / Fibrose Pulmonar Idiopática Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonias Intersticiais Idiopáticas / Fibrose Pulmonar Idiopática Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão